Literature DB >> 15523195

Ocular rosacea: an update on pathogenesis and therapy.

Donald U Stone1, James Chodosh.   

Abstract

PURPOSE OF REVIEW: Ocular rosacea is a common and potentially blinding eye disorder with an uncertain etiology. Therapies currently in vogue for ocular rosacea have not been rigorously studied with regards to specific indications, optimal dosing regimens, or treatment efficacy. This review will summarize the recent literature with regards to etiology and therapy of ocular rosacea, and will also examine current thinking about the parent disorder, acne rosacea. RECENT
FINDINGS: Comparatively few papers on ocular rosacea were published in the past year. Recent articles on the prevalence of ocular rosacea in patients with acne rosacea suggested that between 6 and 18% of acne rosacea patients have signs or symptoms of ocular rosacea, but few cases were confirmed by an ophthalmologist. Recent articles on the pathogenesis of ocular rosacea have focused on the role of bacterial lipases, and interleukin-1alpha and matrix metalloproteinases in the blepharitis and corneal epitheliopathy, respectively. Other reports highlighted the presence of the disorder in children, and the lack of masked, placebo-controlled studies for those therapies currently in common use.
SUMMARY: The epidemiology, etiology, and optimal therapy of ocular rosacea remain to be determined, and will require a more concerted effort to delineate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523195

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  10 in total

1.  Rosacea: a review.

Authors:  Brittney Culp; Noah Scheinfeld
Journal:  P T       Date:  2009-01

Review 2.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

Review 3.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

4.  Eyelid edema.

Authors:  Mirwat S Sami; Charles N S Soparkar; James R Patrinely; Robert N Tower
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

5.  Ocular acne rosacea in tertiary eye center in Saudi Arabia.

Authors:  Mohammad A Al-Amry; Huda A Al-Ghadeer
Journal:  Int Ophthalmol       Date:  2016-12-30       Impact factor: 2.031

6.  Impact of the COVID-19 Pandemic on the Incidence and Characteristics of Culture-Positive Microbial Keratitis at a Tertiary Eye Hospital in the UK.

Authors:  Luke Michaels; Jay Richardson; Andrew Walkden; Fiona Carley
Journal:  Clin Ophthalmol       Date:  2022-08-10

Review 7.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

8.  Clinical Findings, Follow-up and Treatment Results in Patients with Ocular Rosacea.

Authors:  İlkay Kılıç Müftüoğlu; Yonca Aydın Akova
Journal:  Turk J Ophthalmol       Date:  2016-01-05

9.  Corneal and conjunctival sensitivity in rosacea patients.

Authors:  Nurgül Örnek; Ayşe Anıl Karabulut; Kemal Örnek; Zafer Onaran; Gülşah Usta
Journal:  Saudi J Ophthalmol       Date:  2015-09-11

10.  Manifestations of ocular rosacea in females with dark skin types.

Authors:  Amal O Al-Balbeesi; Eman A Almukhadeb; Mona R Halawani; Ghada A Bin Saif; Samir M Al Mansouri
Journal:  Saudi J Ophthalmol       Date:  2019-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.